Jinger A. Doe, Ph.D. - Publications
Affiliations: | 2011 | Cell and Molecular Pharmacology and Physiology | University of Nevada, Reno, Reno, NV, United States |
Area:
Cell Biology, PathologyYear | Citation | Score | |||
---|---|---|---|---|---|
2017 | Doe J, Kaindl AM, Jijiwa M, de la Vega M, Hu H, Griffiths GS, Fontelonga TM, Barraza P, Cruz V, Van Ry P, Ramos JW, Burkin DJ, Matter ML. PTRH2 gene mutation causes progressive congenital skeletal muscle pathology. Human Molecular Genetics. PMID 28175314 DOI: 10.1093/Hmg/Ddx048 | 0.644 | |||
2015 | Griffiths GS, Doe J, Jijiwa M, Van Ry P, Cruz V, de la Vega M, Ramos JW, Burkin DJ, Matter ML. Bit-1 is an essential regulator of myogenic differentiation. Journal of Cell Science. 128: 1707-17. PMID 25770104 DOI: 10.1242/Dev.125765 | 0.61 | |||
2011 | Doe JA, Wuebbles RD, Allred ET, Rooney JE, Elorza M, Burkin DJ. Transgenic overexpression of the α7 integrin reduces muscle pathology and improves viability in the dy(W) mouse model of merosin-deficient congenital muscular dystrophy type 1A. Journal of Cell Science. 124: 2287-97. PMID 21652631 DOI: 10.1242/Jcs.083311 | 0.575 | |||
2010 | Neveux I, Doe J, Leblanc N, Valencik ML. Influence of the extracellular matrix and integrins on volume-sensitive osmolyte anion channels in C2C12 myoblasts. American Journal of Physiology. Cell Physiology. 298: C1006-17. PMID 20164377 DOI: 10.1152/Ajpcell.00359.2009 | 0.321 | |||
Show low-probability matches. |